1. From the Sarah Cannon Research Institute, Nashville, TN; Division of Hematology/Oncology, University of North Carolina at Chapel Hill, Chapel Hill; Duke University Medical Center, Durham; GlaxoSmithKline Inc, Research Triangle Park, NC; and Case Western Reserve University, Cleveland, OH